PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 35409380-1 2022 Branched chain amino acids (BCAAs), leucine, isoleucine and valine, are essential amino acids widely studied for their crucial role in the regulation of protein synthesis mainly through the activation of the mTOR signaling pathway and their emerging recognition as players in the regulation of various physiological and metabolic processes, such as glucose homeostasis. Isoleucine 45-55 mechanistic target of rapamycin kinase Homo sapiens 208-212 28413737-2 2017 Recently, a number of studies have revealed that branched-chain amino acids (BCAAs) (leucine, isoleucine, and valine) play an important role in the regulation of protein synthesis by activating mammalian target of rapamycin (mTOR) in pancreatic beta cells. Isoleucine 94-104 mechanistic target of rapamycin kinase Homo sapiens 194-223 28413737-2 2017 Recently, a number of studies have revealed that branched-chain amino acids (BCAAs) (leucine, isoleucine, and valine) play an important role in the regulation of protein synthesis by activating mammalian target of rapamycin (mTOR) in pancreatic beta cells. Isoleucine 94-104 mechanistic target of rapamycin kinase Homo sapiens 225-229 27236753-8 2016 Whereas mTOR was not very sensitive to changes in insulin or acetate levels, it was highly sensitive to leucine and isoleucine, and this signal appeared to be effectively transduced to casein synthesis. Isoleucine 116-126 mechanistic target of rapamycin kinase Homo sapiens 8-12 27490818-1 2016 BACKGROUND: The proteinogenic branched-chain amino acids (BCAAs) valine, leucine and isoleucine might play an unrecognised crucial role in the development of depression through their activation of the mammalian target of rapamycin (mTor) pathway. Isoleucine 85-95 mechanistic target of rapamycin kinase Homo sapiens 201-230 27490818-1 2016 BACKGROUND: The proteinogenic branched-chain amino acids (BCAAs) valine, leucine and isoleucine might play an unrecognised crucial role in the development of depression through their activation of the mammalian target of rapamycin (mTor) pathway. Isoleucine 85-95 mechanistic target of rapamycin kinase Homo sapiens 232-236 26500112-9 2015 The key residues involved in binding of PKI-179 were Ala-805 in PI3Kgamma and Ile-2163 in mTOR as they have lost maximum accessible surface area due to binding. Isoleucine 78-81 mechanistic target of rapamycin kinase Homo sapiens 90-94 24359813-0 2014 Isoleucine, leucine, methionine, and threonine effects on mammalian target of rapamycin signaling in mammary tissue. Isoleucine 0-10 mechanistic target of rapamycin kinase Homo sapiens 58-87 24359813-10 2014 Isoleucine and Thr positively affected mTOR phosphorylation. Isoleucine 0-10 mechanistic target of rapamycin kinase Homo sapiens 39-43 22298573-3 2012 Omission of L-arginine, L-isoleucine, L-leucine, or all EAA reduced (P < 0.05) mammalian target of rapamycin (mTOR; Ser2448) and ribosomal protein S6 (rpS6; Ser235/236) phosphorylation in MAC-T cells. Isoleucine 24-36 mechanistic target of rapamycin kinase Homo sapiens 82-111 22298573-3 2012 Omission of L-arginine, L-isoleucine, L-leucine, or all EAA reduced (P < 0.05) mammalian target of rapamycin (mTOR; Ser2448) and ribosomal protein S6 (rpS6; Ser235/236) phosphorylation in MAC-T cells. Isoleucine 24-36 mechanistic target of rapamycin kinase Homo sapiens 113-117